Swiss National Bank
ADVM

Swiss National Bank’s Adverum Biotechnologies ADVM Stock Holding History

Swiss National Bank’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,370
Closed -$290K – 2720
2021
Q3 		$290K Hold
13,370
– – ﹤0.01% 2615
2021
Q2 		$468K Hold
13,370
– – ﹤0.01% 2626
2021
Q1 		$1.32M Buy
13,370
+460
+4% +$55.2K ﹤0.01% 2233
2020
Q4 		$1.4M Sell
12,910
-1,060
-8% -$131K ﹤0.01% 2126
2020
Q3 		$1.44M Buy
13,970
+570
+4% +$85.4K ﹤0.01% 1883
2020
Q2 		$2.8M Buy
13,400
+1,900
+17% +$337K ﹤0.01% 1517
2020
Q1 		$1.12M Buy
11,500
+1,020
+10% +$119K ﹤0.01% 1762
2019
Q4 		$1.21M Buy
+10,480
New +$924K ﹤0.01% 2031
2015
Q4 		– Sell
-2,208
Closed -$182K – 2644
2015
Q3 		$182K Buy
2,208
+320
+17% +$40.9K ﹤0.01% 2507
2015
Q2 		$307K Buy
1,888
+50
+3% +$16.9K ﹤0.01% 2442
2015
Q1 		$745K Buy
1,838
+798
+77% +$337K ﹤0.01% 1926
2014
Q4 		$562K Buy
+1,040
New +$401K ﹤0.01% 2106

Other funds holding ADVM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Swiss National Bank's ADVM Position: Q4 2021 in Review

Swiss National Bank sold out of Adverum Biotechnologies (ADVM) in Q4 2021, closing a stake of 13,370 shares — an estimated $290K sold.

Swiss National Bank first reported a position in ADVM in Q4 2014 and held it in 12 quarters. The position peaked at $2.8M in Q2 2020. 98 funds tracked by Wall St. Rank hold ADVM as of Q4 2021.

  • Swiss National Bank reported no remaining Adverum Biotechnologies position as of Q4 2021 after selling out during the quarter.
  • Swiss National Bank sold 13,370 Adverum Biotechnologies shares in Q4 2021, an estimated $290K.
  • Swiss National Bank first reported a position in Adverum Biotechnologies in Q4 2014 and held it in 12 quarters.
  • Swiss National Bank's Adverum Biotechnologies position peaked at $2.8M in Q2 2020.
  • 98 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2021.

Based on Swiss National Bank's 13F filing for Q4 2021, filed 8 Feb 2022.